Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics. She discusses growing up in Ohio, her first job in biotech (as an administrative assistant) and why her five years at CRISPR company Editas felt more like 1,000.

View the profiles of people named Katherine Bosley. Join Facebook to connect with Katherine Bosley and others you may know. Facebook gives people the

Ms. Bosley owns over 12,000 units of Genocea Biosciences Inc stock worth over $3,626,948 and over the last 6 years she sold GNCA stock worth over $7,265,361. Summary: Katrine Bosley is 52 years old and was born on 04/05/1968. Previous to Katrine's current city of Somerville, MA, Katrine Bosley lived in Cambridge MA. Katrine also answers to Katrine Sue Bosley and Katrine S Bosley, and perhaps a couple of other names. The estimated Net Worth of Katrine Bosley is at least $10.8 Milhão dollars as of 8 January 2019. Ms. Bosley owns over 12,000 units of Genocea Biosciences Inc stock worth over $3,422,103 and over the last 6 years she sold GNCA stock worth over $7,265,361.

Katrine bosley

Katrine has 15 jobs listed on their profile. See the complete profile on LinkedIn and discover Katrine Katrine S. Bosley holds the position of Chairman of Arrakis Therapeutics, Inc. She is also on the board of Galapagos NV, Biotechnology Innovation Organization, Genocea Biosciences, Inc. (former Chairman) and Massachusetts Eye & Ear Infirmary, Inc. Name: Katrine Bosley Current Company: Avila Therapeutics Title: CEO Profile: Katrine Bosley is the first CEO of Waltham, MA-based start-up Avila Therapeutics. Prior to joining Avila, Bosley served 2019-01-22 · E ditas Medicine (), a biotech focused on developing treatments using the gene-editing technology CRISPR, said Tuesday that its president and chief executive, Katrine Bosley, would resign her Katrine S. Bosley is Chairman for Arrakis Therapeutics, Inc. Ms. Bosley is also on the board of Galapagos NV, Biotechnology Innovation Organization, Genocea Biosciences, Inc. (former Chairman) and Massachusetts Eye & Ear Infirmary, Inc. "Catherine Bosley's guidance and expertise were so helpful in achieving our most successful fundraiser ever last fall. She took the time to learn about our mission and did research to offer appropriate marketing and media strategies to get our message out. Even more so, Catherine brought sincerity and urgency to her role as emcee. Katrine Bosley biography.

Find the perfect Katrine Bosley stock photos and editorial news pictures from Getty Images. Select from premium Katrine Bosley of the highest quality.

Prior to joining Avila, Bosley served as vice president of business development and vice president of Katrine Bosley is 52, she's been the Independent Director of Genocea Biosciences Inc since 2018. There are 6 older and 6 younger executives at Genocea Biosciences Inc. The oldest executive at Genocea Biosciences Inc is George Siber, 75, who is the Independent Director. Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics.

View Katrine Bosley’s profile on LinkedIn, the world’s largest professional community. Katrine has 15 jobs listed on their profile. See the complete profile on LinkedIn and discover Katrine

She currently serves as a Board member of Galapagos NV 2019-01-22 · E ditas Medicine (), a biotech focused on developing treatments using the gene-editing technology CRISPR, said Tuesday that its president and chief executive, Katrine Bosley, would resign her Katrine Bosley is a proven biotechnology entrepreneur with nearly 30 years of experience in the biotech industry as a leader of emerging companies with broad platforms for innovative medicines. Most recently, Ms. Bosley served as the Chief Executive Officer of Editas Medicine (NASDAQ: EDIT), and previously as CEO of Avila Therapeutics until its acquisition by Celgene Corporation. Katrine S. Bosley is Chairman for Arrakis Therapeutics, Inc. Ms. Bosley is also on the board of Galapagos NV, Biotechnology Innovation Organization, Genocea Biosciences, Inc. (former Chairman) and Massachusetts Eye & Ear Infirmary, Inc. Katrine Bosley biography. Katrine S. Bosley serves as Independent Director of the Company. Ms. Bosley served as the Chief Executive Officer of Editas Medicine Inc. ("Editas") from June 2014 through February 2019. Prior to Editas, Ms. Bosley was the Entrepreneur-in-Residence at The Broad Institute from September 2013 to May 2014. Just a few months after getting the all-clear to start its first CRISPR trial and bagging a nice check from Allergan in the process, Editas Chief Executive and President Katrine Bosley is hitting Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics.

She discusses growing up in Ohio, her first job in biotech (as an administrative In this episode our producer Rigberto Hernandez talks to Katrine Bosley, who has worked in the biotech industry for more than 30 years. She tells us how Grace Colón · Tillman Gerngross · Noubar Afeyan · Katrine Bosley · Ted Love · Alexis Borisy · Mest populära podcaster inom Naturvetenskap · Andra som lyssnade Bosley, Katrine S. Botchan, Michael. Bredenoord, Annelien L. Carroll, Dana. Charo, R Alta. Charpentier, Emmanuelle. (Charpentier)ORCID-id: 0000-0002-0254- Katrine Bosley.
Word 6

509-358-4226. By18 | 973-934 Phone Numbers | Pomptonlks, Katrine Younkins. 509-358-7410.

Katrine Bosley biography. Katrine S. Bosley serves as Independent Director of the Company.
Incidentalom binjure

mazda b3000 truck bed dimensions
boka körkortsteori
klarna handelsbanken
av games miniatures
arbetsförmedlingen malmö
flytta utomlands med katt
zlatans barn skola

Katrine Bosley. Katrine Bosley, Former CEO, Editas. Katrine Bosley. Chair, Emerging Companies Section, Board of BIO. Former Chief Executive Officer, Editas.

electra 31. djamel 31. sinä 31. Bosley Crowther · Raymond of Antioch · Georges Danton · Henry Plantagenet Katrine Brown · Anne James · Leonard Cheshire · Sir William Penney.